Additional analysis for PIK3CA in different stages of cervical cancer obtained from an available clinical information dataset, GSE9750, indicated that high PIK3CA amplification was significantly associated with advanced stages in cervical cancer (Figure 1F, p < 0.05). This evidence concerns the gene PIK3CA and cervical cancer.